Journal ArticleOPEN ACCESS

Finerenone and Atrial Fibrillation in Heart Failure

  • Matsumoto S
  • Henderson A
  • Jhund P
  • et al.
JAMA Cardiology (2025) 10(7) 696
DOI: 10.1001/jamacardio.2025.0848
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) randomized clinical trial examines the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction according to the presence and type of atrial fibrillation.

Cite

CITATION STYLE

APA

Matsumoto, S., Henderson, A. D., Jhund, P. S., Bauersachs, J., Chioncel, O., Claggett, B. L., … McMurray, J. J. V. (2025). Finerenone and Atrial Fibrillation in Heart Failure. JAMA Cardiology, 10(7), 696. https://doi.org/10.1001/jamacardio.2025.0848

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free